Cellosaurus logo
expasy logo

Cellosaurus KOLF2.1J (CVCL_B5P3)

[Text version]
Cell line name KOLF2.1J
Synonyms KOLF 2.1J; WTSIi018-B-12; JAXi019-A-12; JIPSC1000
Accession CVCL_B5P3
Resource Identification Initiative To cite this cell line use: KOLF2.1J (RRID:CVCL_B5P3)
Comments From: The Jackson Laboratory; Bar Harbor; USA.
Population: Caucasian; British.
Omics: Genome sequenced.
Derived from site: In situ; Skin; UBERON=UBERON_0002097.
Cell type: Fibroblast of skin; CL=CL_0002620.
Sequence variations
  • Mutation; HGNC; 18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=36459969).
  • Mutation; HGNC; 2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
  • Mutation; HGNC; 2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_9S58 (HPSI0114i-kolf_2-C1)
Children:
CVCL_D1J6 (KOLF2.1J AAVS1-TREG3-NGN2)CVCL_D6I7 (KOLF2.1J DJ1 L166P clone 1)CVCL_D6I8 (KOLF2.1J DJ1 L166P clone 2)
CVCL_C7TY (KOLF2.1J PPM1H KO)CVCL_C8FQ (KOLF2.1J TH-TdTomato)CVCL_D6RH (WTSIi018-B-19)
CVCL_D6RI (WTSIi018-B-20)
Sex of cell Male
Age at sampling 55-59Y
Category Induced pluripotent stem cell
STR profile Source(s): PubMed=38518401

Markers:
AmelogeninX,Y
CSF1PO11,12
D1S165614,18.3
D2S133817,19
D3S135816
D5S81812,13
D6S104312,20
D7S8209,11
D8S117911,14
D12S39118,22
D13S3179,10
D16S5399,13
D18S5112,17
D19S43314,15
D21S1131,32.2
FGA21
Penta D12,15
Penta E10,12
TH016,9.3
TPOX8,11
vWA14

Run an STR similarity search on this cell line
Web pages https://www.jax.org/jax-mice-and-services/ipsc/cells-collection
Publications

PubMed=36459969; DOI=10.1016/j.stem.2022.11.004; PMCID=PMC9782786
Pantazis C.B., Yang A., Lara E., McDonough J.A., Blauwendraat C., Peng L.-R., Oguro H., Kanaujiya J., Zou J.-Z., Sebesta D., Pratt G., Cross E., Blockwick J., Buxton P., Kinner-Bibeau L.B., Medura C., Tompkins C., Hughes S., Santiana M., Faghri F., Nalls M.A., Vitale D., Ballard S., Qi Y.A., Ramos D.M., Anderson K.M., Stadler J., Narayan P., Papademetriou J., Reilly L., Nelson M.P., Aggarwal S., Rosen L.U., Kirwan P., Pisupati V., Coon S.L., Scholz S.W., Priebe T., Ottl M., Dong J., Meijer M., Janssen L.J.M., Lourenco V.S., van der Kant R., Crusius D., Paquet D., Raulin A.-C., Bu G.-J., Held A., Wainger B.J., Gabriele R.M.C., Casey J.M., Wray S., Abu-Bonsrah K.D., Parish C.L., Beccari M.S., Cleveland D.W., Li E., Rose I.V.L., Kampmann M., Calatayud Aristoy C., Verstreken P., Heinrich L., Chen M.Y., Schule B., Dou D., Holzbaur E.L.F., Zanellati M.C., Basundra R., Deshmukh M., Cohen S., Khanna R., Raman M., Nevin Z.S., Matia M., Van Lent J., Timmerman V., Conklin B.R., Chase K.J., Zhang K., Funes S., Bosco D.A., Erlebach L., Welzer M., Kronenberg-Versteeg D., Lyu G.-C., Arenas E., Coccia E., Sarrafha L., Ahfeldt T., Marioni J.C., Skarnes W.C., Cookson M.R., Ward M.E., Merkle F.T.
A reference human induced pluripotent stem cell line for large-scale collaborative studies.
Cell Stem Cell 29:1685-1702.e22(2022)

PubMed=38518401; DOI=10.1016/j.scr.2024.103395
Binder S., Ramachandran H., Haslinger D., Hildebrandt B., Dobner J., Haarmann-Stemmann T., Chiocchetti A.G., Rossi A.
CRISPR/Cas9-mediated editing of ACTB in induced pluripotent stem cells: a model for investigating human ACTB loss-of-function and genetic adaptive responses.
Stem Cell Res. 77:103395-103395(2024)

Cross-references
Cell line databases/resources hPSCreg; WTSIi018-B-12
Encyclopedic resources Wikidata; Q117704576
Entry history
Entry creation21-Mar-2023
Last entry update10-Sep-2024
Version number4